Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
27.07
-0.03 (-0.11%)
At close: Feb 21, 2025, 4:00 PM
27.08
+0.01 (0.04%)
After-hours: Feb 21, 2025, 5:59 PM EST
Edgewise Therapeutics Employees
Edgewise Therapeutics had 88 employees as of December 31, 2023. The number of employees increased by 29 or 49.15% compared to the previous year.
Employees
88
Change (1Y)
29
Growth (1Y)
49.15%
Revenue / Employee
n/a
Profits / Employee
-$1,412,432
Market Cap
2.56B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 88 | 29 | 49.15% |
Dec 31, 2022 | 59 | 28 | 90.32% |
Dec 31, 2021 | 31 | 12 | 63.16% |
Dec 31, 2020 | 19 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
EWTX News
- 4 weeks ago - Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development - Business Wire
- 5 weeks ago - Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025 - Business Wire
- 6 weeks ago - Edgewise Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025 - Business Wire
- 7 weeks ago - Edgewise: Remains A Buy After Latest Becker Muscular Dystrophy Data - Seeking Alpha
- 2 months ago - Edgewise Therapeutics' Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease - Benzinga
- 2 months ago - Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker) - Business Wire
- 2 months ago - Edgewise Provides Statement Regarding Company's Relationship with Dr. Han Phan at Rare Disease Research - Business Wire
- 3 months ago - Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024 - Business Wire